July 27, 2015
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), has awarded James McKerrow, MD, PhD, dean of the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, with a 2015 New Therapeutic Uses Award.
September 16, 2013
Biologists at the University of California, San Diego have developed a revolutionary new method for identifying and characterizing antibiotics, an advance that could lead to the discovery of new antibiotics to treat antibiotic resistant bacteria.
January 22, 2014
Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound. Their study, published this week in PNAS, may open new avenues for natural product discoveries and drug development.
January 3, 2020
UC San Diego’s Seth Cohen and his research team, including colleagues at Germany’s Ruhr University Bochum led by Nils Metzler-Nolte, used a new type of metal-based molecular building block to serve as the basis for developing new therapeutic drugs. Their work is published in Chemical Science.
January 18, 2022
Countering a rising antibiotic resistance crisis, doctors now prescribe combinations of antibiotics. Yet many risks are involved with such multi-drug combinations. Scientists have developed a way to help doctors evaluate outcomes for different drug pairs and boost the odds of successful treatment.
May 6, 2024
Researchers from University of California San Diego have developed a new AI tool to that generate new drug candidates for cancer, which could help streamline the typically laborious drug discovery process.
September 26, 2022
In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.
January 9, 2012
The new UC San Diego-Roche Extending Innovation Network (EIN) program has been launched with selection of its first three research projects at the University of California, San Diego School of Medicine.
November 2, 2015
…used to predict a drug’s side effects on different patients. The proof of concept study is aimed at determining how different individuals will respond to a drug treatment and could help assess whether a drug is suitable for a particular patient based on measurements taken from the patient’s blood.
November 18, 2015
…health. Cell proteins called drug transporters have been known to prevent chemotherapy and other drugs from reaching cells in disease treatment. Hamdoun and his colleagues have identified the role of a drug transporter in the early life stages of the sea urchin gut. The results could lead to new ways…
